High Vista Strategies LLC C4 Therapeutics, Inc. Transaction History

High Vista Strategies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$5.06 - $26.46 $175,885 - $919,749	-34,760 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$19.99 - $33.23 $65,307 - $108,562	3,267 Added 10.37%	34,760 $843,000
Q4 2021 Feb 14, 2022	BUY	$29.39 - $46.86 $63,247 - $100,842	2,152 Added 7.33%	31,493 $1.01 Million
Q3 2021 Nov 15, 2021	BUY	$35.91 - $50.5 $273,346 - $384,406	7,612 Added 35.03%	29,341 $1.31 Million
Q2 2021 Aug 16, 2021	BUY	$30.39 - $42.18 $125,875 - $174,709	4,142 Added 23.55%	21,729 $822,000
Q1 2021 May 17, 2021	BUY	$31.96 - $46.5 $562,080 - $817,795	17,587 New	17,587 $651,000

130

63.5M

670K

54.8K

Ticker CCCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,913,800
Market Cap $208M
Description
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.